The PQI Podcast is presented by NCODA and hosted by
Ginger Blackmon, PharmD, Manager of Patient-Centered Communications

We look forward to bringing you a new way to hear first-hand from clinical and administrative experts across the country on the latest in oncology and how they utilize PQIs to positively impact their practice and overall care, shared stories from cancer survivors on life changing events, and current industry issues that our guests are focusing on to ensure a better future for patients.

Season 2, Episode 2: Disparities in Chronic Pain Management

On today’s episode of The PQI Podcast we welcome Krystal Preston, PharmD, BCPS and Randall Knoebel, PharmD, BCOP.

Dr. Krystal Preston earned her Doctor of Pharmacy from Chicago State University and is Board Certified in Pharmacotherapy. She recently began a new career journey working as a Clinical Specialty Pharmacist-Oncology with Amita Health St. Joseph Hospital Chicago. She also works part time as a Clinical Pharmacist at the University of Chicago Comer Children’s Hospital. She has made it her life mission to end disparities in healthcare.

Dr. Randall Knoebel obtained his Doctor of Pharmacy from Midwestern University, Chicago College of Pharmacy.  He worked as a clinical pharmacy specialist in Leukemia for several years before moving into pharmacy leadership positions, now working as Pharmacy Director of Health Analytics and Drug Policy in UChicago Medicine’s Department of Pharmacy. He also serves as the PGY1 pharmacy residency program director; and as the pharmacy director of Pain Stewardship at the University of Chicago a committee charged to lead efforts institutionally to improve the quality and safety of pain care.

Today we discuss disparities in chronic pain management and Krystal’s personal story in dealing with Sickle Cell disease. Randy’s recent article can be found here:

This episode is brought to you by Cardinal Health™ VitalSource™ GPO. With a deep understanding of industry challenges, VitalSource™ GPO Site of Care Dispensing Solutions has helped practices resolve transparency issues related to DIR fees with a unique DIR alert solution. Austin Cox, PharmD and Clinical Pharmacist at Alabama Oncology describes the alert program as a “a game changer” for his practice. The program gives them insight into hidden fees upon claim adjudication, allowing them to make more informed decisions for the practice. To connect with a Cardinal Health team member to learn more, go to

Season 2, Episode 1: Cancer and the Microbiome

On today’s episode of The PQI Podcast we welcome Nadim Ajami, Ph.D. Nadim serves as the Executive Director of Scientific Research for the Program for Innovative Microbiome and Translational Research (PRIME-TR) at The University of Texas, MD Anderson Cancer Center. Nadim earned his PhD from Baylor College of Medicine in Houston, Texas and his career goals are centered on addressing unmet clinical needs with translational research. He has worked closely with clinicians in various settings to identify opportunities to study microbe-host interactions in the context of health and disease.

Today we discuss the Prime-TR program and microbiome as it relates to cancer and anti-cancer therapies. More information on the Prime-TR program can be found here:

Podcast guests’ comments reflect their experiences and opinions and should not be used as a substitute for medical judgement. Important notice: NCODA has developed this PQI Podcast platform. This platform is intended as an educational aid and does not provide individual medical advice and does not substitute for the advice of a qualified healthcare professional. This platform does not cover all existing information related to the possible uses, directions, doses, precautions, warning, interactions, adverse effects, or risks associated with any medication discussed in the platform and is not intended as a substitute for the advice of a qualified healthcare professional. The materials contained in this platform are for informational purposes only and do not constitute or imply endorsement, recommendation, or favoring of this medication by NCODA, which assumes no liability for and does not ensure the accuracy of the information presented. NCODA does not make any representations with respect to the medications whatsoever, and any and all decisions, with respect to such medications, are at the sole risk of the individual consuming the medication. All decisions related to taking this medication should be made with the guidance and under the direction of a qualified healthcare professional.